Clinical and Genetic Characteristics of Late-onset Stargardt's Disease

被引:146
|
作者
Westeneng-van Haaften, Sarah C. [1 ]
Boon, Camiel J. F. [1 ]
Cremers, Frans P. M. [2 ,3 ]
Hoefsloot, Lies H. [2 ]
den Hollander, Anneke I. [1 ,2 ,3 ]
Hoyng, Carel B. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands
关键词
MACULAR DEGENERATION; FUNDUS FLAVIMACULATUS; ABCR ABCA4; CHOROIDAL NEOVASCULARIZATION; RETINAL DYSTROPHIES; BIOCHEMICAL DEFECTS; MOUSE MODEL; MUTATIONS; AUTOFLUORESCENCE; SUPPLEMENTATION;
D O I
10.1016/j.ophtha.2012.01.005
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To describe the genotype and phenotype of patients with a late-onset Stargardt's disease (STGD1). Design: Retrospective case series. Participants: Twenty-one unrelated STGD1 patients with an age at onset of >= 45 years and >= 1 rare variant in the ABCA4 gene. Methods: Ophthalmologic examination, including best-corrected visual acuity (VA), Amsler grid testing, fundus photography, fluorescein angiography (FA), spectral-domain optical coherence tomography (OCT), fundus autofluorescence (FAF) imaging, full-field electroretinography (ERG), multifocal ERG, and central visual field testing. Analysis of the ABCA4 gene was performed using microarray analysis, sequencing, and multiplex ligation-dependent probe amplification. In addition, the PRPH2 and CFH genes were sequenced. Main Outcome Measures: Age at onset, VA, fundus appearance, FA, FAF, and OCT findings; ABCA4 mutations; and genotype-phenotype correlation. Results: The mean age at onset was 55 years (range, 45-72 years). Seven patients were diagnosed without visual symptoms (age range, 45-83 years). The VA was >= 20/40 in 24 eyes of 14 patients (59%) owing to foveal sparing. On ophthalmoscopy, late-onset STGD1 showed flavimaculatus flecks (15 patients), small flecks surrounding mottled foveal changes (3 patients), extensive chorioretinal atrophy (2 patients), or small yellowish spots in the macula (1 patient). The fundus flecks showed increased autofluorescence on FAF. The choroidal background fluorescence on FA was obscured in 16 patients (80%). We found a single heterozygous ABCA4 variant in 11 patients (52%), 2 compound heterozygous variants in 8 patients (38%), and a homozygous variant in 2 patients (10%). No PRPH2 or CFH mutations were detected. Conclusions: Late-onset STGD1 is at the mild end of the spectrum of retinal dystrophies caused by ABCA4 mutations. The VA is frequently preserved in late-onset STGD1 patients owing to foveal sparing. This phenotype may be caused by 1 or 2 ABCA4 variants. The differential diagnosis between late-onset STGD1 and age-related macular degeneration may be challenging. A thorough clinical and genetic analysis makes a distinction possible, which is important for clinical and genetic counseling. Financial Disclosure(s): The authors have no proprietary or commercial interest in any of the materials discussed in this article. Ophthalmology 2012;119:1199-1210 (C) 2012 by the American Academy of Ophthalmology.
引用
收藏
页码:1199 / 1210
页数:12
相关论文
共 50 条
  • [21] Assessment of the genetic variance of late-onset Alzheimer's disease
    Ridge, Perry G.
    Hoyt, Kaitlyn B.
    Boehme, Kevin
    Mukherjee, Shubhabrata
    Crane, Paul K.
    Haines, Jonathan L.
    Mayeux, Richard
    Farrer, Lindsay A.
    Pericak-Vance, Margaret A.
    Schellenberg, Gerard D.
    Kauwe, John S. K.
    [J]. NEUROBIOLOGY OF AGING, 2016, 41
  • [22] CLINICAL CHARACTERISTICS OF EARLY-ONSET AND LATE-ONSET ALZHEIMERS-DISEASE
    HUFF, FJ
    GROWDON, JH
    CORKIN, S
    [J]. ANNALS OF NEUROLOGY, 1984, 16 (01) : 119 - 119
  • [23] Genetic discoveries and advances in late-onset Alzheimer's disease
    Rezazadeh, Maryam
    Hosseinzadeh, Hassan
    Moradi, Mohsen
    Esfahani, Behnaz Salek
    Talebian, Shahrzad
    Parvin, Shaho
    Gharesouran, Jalal
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 16873 - 16884
  • [24] The relevance of genetic testing in late-onset Huntington's disease
    Gallucci, DC
    Frisoni, GB
    Trabucchi, M
    Appollonio, IM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (05) : 609 - 611
  • [25] Late onset Huntington's disease: clinical and genetic characteristics of 20 cases
    Cislaghi, G.
    Romano, L.
    Capiluppi, E.
    Suardelli, M.
    Lovati, C.
    Bertora, P.
    Mariani, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 172 - 172
  • [26] Neuropathology of preclinical and clinical late-onset Alzheimer's disease
    Troncoso, JC
    Cataldo, AM
    Nixon, RA
    Barnett, JL
    Lee, MK
    Checler, F
    Fowler, DR
    Smialek, JE
    Crain, B
    Martin, LJ
    Kawas, CH
    [J]. ANNALS OF NEUROLOGY, 1998, 43 (05) : 673 - 676
  • [27] Genetic analyses of late-onset Alzheimer disease
    Tanzi, R
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S25 - S25
  • [28] Clinical characteristics of late-onset myasthenia gravis
    Sun, Chenjing
    Ren, Zhuangzhuang
    Miao, Xiuling
    Zheng, Yanxu
    Zhang, Jun
    Qi, Xiaokun
    Liu, Jianguo
    Qiu, Feng
    [J]. HELIYON, 2024, 10 (07)
  • [29] Clinical characteristics of late-onset neuromyelitis optica
    Ahn, S. -W.
    Min, J. -H.
    Kim, B. -J.
    Lee, K. -H.
    Cho, J. -Y.
    Kim, B. -J.
    Kim, H. -J.
    An, J. -Y.
    Park, M. -S.
    Kim, N. -H.
    Shin, H. -Y.
    Kwon, K. -H.
    Son, E. -H.
    Kim, J. -K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S312 - S312
  • [30] Late-Onset Wilson's Disease
    Zigrai, Miroslav
    Vyskocil, Milan
    Tothova, Andrea
    Veres, Peter
    Bluska, Peter
    Valkovic, Peter
    [J]. FRONTIERS IN MEDICINE, 2020, 7